Dengue Virus NS1 Antibody (DA034)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-14838
Key Product Details
Species Reactivity
Virus
Applications
ELISA, Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # DA034
Concentration
1 mg/ml
Product Specifications
Immunogen
Dengue virus cell lysate
Reactivity Notes
Dengue Pan-Serotype
Specificity
This antibody is specific for the NS1 protein of Dengue virus, detecting NS1 from all four Dengue virus serotypes. It demonstrates negligible cross-reactivity with NS1 proteins from Zika virus. A small amount of cross-reactivity has been observed with the NS1 protein from West Nile Virus in a direct ELISA. No cross-reactivity is seen with Chikungunya virus proteins (E1, E2 and C).
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for Dengue Virus NS1 Antibody (DA034)
Immunocytochemistry/ Immunofluorescence: Dengue Virus NS1 Antibody (DA034) [NBP3-14838]
Immunocytochemistry/Immunofluorescence: Dengue Virus NS1 Antibody (DA034) [NBP3-14838] - Immunofluorescence was carried out in Vero cells. Cells were seeded on coverslips and infected with DENV (serotypes 1, 2, 3 and 4) for 48h at MOI 1. Control coverslips consisted of uninfected Vero cells. After fixation with 4% PFA, samples were stained with Mouse anti-Dengue virus NS1 antibody (Dengue Virus NS1 Antibody or Dengue Virus 2 premembrane (prM) Envelope antibody. Antibody was diluted 1:500 and Triton X-100 was used as detergent. Imaging was performed using a Leica SP5 confocal microscope. Immunofluorescence was observed in DENV serotype 1 and DENV serotype 3 infected cells, using Dengue Virus NS1 antibody or Dengue Virus 2 premembrane (prM) Envelope antibody. DENV serotype 1 infected cells (DV1), stained with Dengue Virus NS1 antibody are shown above.ELISA: Dengue Virus NS1 Antibody (DA034) [NBP3-14838]
ELISA: Dengue Virus NS1 Antibody (DA034) [NBP3-14838] - ELISA assay was performed with antigens at 0.5ug/ml and antibody at 1ug/ml. ELISA plates were coated on bench overnight in 0.1M Carbonate pH 9.6, 100ul/well, washed once in wash buffer 300ul/well (TBS + 0.1% Tween 20) and blocked for 2 hr in 1% BSA in D-PBS (300ul/well). Antibodies, diluted to working strength in diluent (DPBS + 1% BSA + 0.05% Tween 20 + 0.2% Proclin 950), were added at 100ul/well and incubated for 2 hr (shaken at ambient temperature), followed by 3 x 300ul/well washes. Goat anti Mouse IgG-HRP diluted 1:2500 in diluent, was added at 100ul/well and incubated with shaking for 1 hr at ambient temperature. Plate then washed 6 x 300ul/well. TMB (KPL Sureblue) was added at 100ul/well. Reaction for screening assay was stopped by addition of 1M HCl (100ul/well) and absorbance read at 450nm.Applications for Dengue Virus NS1 Antibody (DA034)
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Suitable for use in direct ELISA and in sandwich ELISA.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS pH 7.4
Preservative
No Preservative
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Dengue Virus NS1
Dengue virus entry into host cells occurs via receptor-mediated endocytosis by receptor molecules including the mannose receptor, heparan sulfate, glycosaminoglycans, and DC-SIGN (1,3). Following attachment, the virus is endocytosed in clathrin-coated vesicles (1,3). Following internalization, clathrin disassembles and endosomal processing occurs, allowing viral fusion, disassembly, and release of viral RNA (1,3). This release results in viral translation and replication, virus assembly and maturation, and eventual exocytosis of the mature virus (1,3). Infection can result in a wide range of clinical symptoms including mild disease such as Dengue fever which is characterized by fever, headache, joint pain, rash, and retro-orbital pain, or severe, life-threatening conditions like Dengue hemorrhagic fever or Dengue shock syndrome which involves vascular permeability and leakage (1-3). Host immune response against infection includes innate immune response via interferon secretion and pro-inflammatory cytokine production, as well as adaptive immune response involving cellular and humoral components like T cell activation and B-cell mediated antibody production (1-3). As far as treatment for Dengue virus infection, there no commercial antiviral agents, though some anti-pyretics and certain phenolic compounds do show promise in treating infection (1-3). However, Resveratol, an antiviral for other Flavivirus, has been shown to directly attack the Dengue virus genome (1). While more work needs to be done, there are some live-attenuated tetravalent Dengue virus vaccine candidates in clinal trials including DENVax and TV003/TV005 (1-3).
References
1. Nanaware N, Banerjee A, Mullick Bagchi S, Bagchi P, Mukherjee A. Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses. Viruses. 2021;13(10):1967. Published 2021 Sep 30. https://doi.org/10.3390/v13101967
2. Harapan H, Michie A, Sasmono RT, Imrie A. Dengue: A Minireview. Viruses. 2020;12(8):829. Published 2020 Jul 30. https://doi.org/10.3390/v12080829
3. Roy SK, Bhattacharjee S. Dengue virus: epidemiology, biology, and disease aetiology. Can J Microbiol. 2021;67(10):687-702. https://doi.org/10.1139/cjm-2020-0572
Long Name
Dengue Virus Nauru/West Pac/1974 Polyprotein
Alternate Names
Dengue NS1, Dengue NS1 protein, Dengue Virus
Additional Dengue Virus NS1 Products
Product Documents for Dengue Virus NS1 Antibody (DA034)
Product Specific Notices for Dengue Virus NS1 Antibody (DA034)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...